Amarin Corp. Plc (AMRN)
13.82
-0.27
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
13.82
0.00 (0.00%)
After-Hours: 20:00
Amarin Enterprise Value : -13.67M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | -13.67M |
| August 20, 2026 | -14.30M |
| August 19, 2026 | -7.583M |
| August 18, 2026 | -12.83M |
| August 17, 2026 | -15.35M |
| August 14, 2026 | -14.09M |
| August 13, 2026 | -12.41M |
| August 12, 2026 | -14.30M |
| August 11, 2026 | -15.35M |
| August 10, 2026 | -13.25M |
| August 07, 2026 | -8.003M |
| August 06, 2026 | -10.10M |
| August 05, 2026 | -6.953M |
| August 04, 2026 | -7.163M |
| August 03, 2026 | -12.62M |
| July 31, 2026 | -10.10M |
| July 30, 2026 | -10.73M |
| July 29, 2026 | -12.20M |
| July 28, 2026 | -16.61M |
| July 27, 2026 | -19.55M |
| July 24, 2026 | -25.02M |
| July 23, 2026 | -23.97M |
| July 22, 2026 | -21.65M |
| July 21, 2026 | -17.03M |
| July 20, 2026 | -23.97M |
| Date | Value |
|---|---|
| July 17, 2026 | -16.82M |
| July 16, 2026 | -11.78M |
| July 15, 2026 | -5.903M |
| July 14, 2026 | -7.793M |
| July 13, 2026 | -0.8627M |
| July 10, 2026 | 2.918M |
| July 09, 2026 | 7.958M |
| July 08, 2026 | 9.008M |
| July 07, 2026 | 15.10M |
| July 06, 2026 | 20.77M |
| July 02, 2026 | 34.21M |
| July 01, 2026 | 36.31M |
| June 30, 2026 | 25.18M |
| June 29, 2026 | 31.56M |
| June 26, 2026 | 31.35M |
| June 25, 2026 | 40.58M |
| June 24, 2026 | 41.84M |
| June 23, 2026 | 32.61M |
| June 22, 2026 | 29.25M |
| June 18, 2026 | 33.87M |
| June 17, 2026 | 28.41M |
| June 16, 2026 | 15.82M |
| June 15, 2026 | 19.60M |
| June 12, 2026 | 17.29M |
| June 11, 2026 | 10.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Neurocrine Biosciences, Inc. | 15.51B |
| Cellectis SA | 280.31M |
| Alkermes Plc | 9.013B |
| Akari Therapeutics Plc | 6.680M |
| Liquidia Corp. | 6.013B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.664M |
| Revenue (Quarterly) | 42.29M |
| Total Expenses (Quarterly) | 49.95M |
| EPS Diluted (Quarterly) | -0.3681 |
| Gross Profit Margin (Quarterly) | 34.00% |
| Profit Margin (Quarterly) | -18.12% |
| Earnings Yield | -9.39% |
| Normalized Earnings Yield | -5.312 |